The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Microarray analysis of gene expression in gastric cancer cells from ascitic fluids before and after capecitabine and oxaliplatin (CapeOX).
 
Osamu Maeda
Honoraria - Taiho Pharmaceutical; Yakult Honsha
 
Kazuhiro Ishiguro
No Relationships to Disclose
 
Kohei Funasaka
No Relationships to Disclose
 
Ryoji Miyahara
No Relationships to Disclose
 
Yoshiki Hirooka
No Relationships to Disclose
 
Hidemi Goto
Honoraria - Ajinomoto; AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Fujifilm; Kyowa Hakko Kirin; Lilly Japan; Mitsubishi Tanabe Pharma; MSD; Otsuka; Taiho Pharmaceutical; Takeda; Zeria Pharmaceutical
Research Funding - Ajinomoto; Asahi Kasei; ASKA Pharmaceutical; Astellas Pharma; AstraZeneca; Bayer Yakuhin; Boston Scientific; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Fujifilm; Gadelius Medical; Kyowa Hakko Kirin; Lilly Japan; Mitsubishi Tanabe Pharma; MSD; Otsuka; Shionogi; Sumitomo Dainippon; Taiho Pharmaceutical; Taisho Toyama Pharma; Takara Bio; Takeda; Tsumura & Co.; Zeria Pharmaceutical
 
Yuichi Ando
Honoraria - ARKRAY; ASKA Pharmaceutical; AstraZeneca; Bayer Holding; Benesse Style Care; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hisamitsu Pharmaceutical; Janssen; Kowa; Kyowa Hakko Kirin; Lilly Japan; Meiji Seika Kaisha; Merck Serono; Nippon Kayaku; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; TERUMO; Yakult Honsha
Consulting or Advisory Role - Boehringer Ingelheim; Daiichi Sankyo; GlaxoSmithKline; Kowa; Novartis; Ono Pharmaceutical; Parexel
Research Funding - Chugai Pharma; Daiichi Sankyo; Eisai; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Merck Serono; Mitsubishi Tanabe Pharma; Mochida Pharmaceutical Co. Ltd.; Nippon Kayaku; Sanofi; Taiho Pharmaceutical; Takeda; Torii Pharmaceutical; Yakult Honsha